FGFR2 and EGFR inhibition in pancreatic cancer (IMAGE)
Caption
A new study from Cold Spring Harbor Laboratory, published in Cancer Research, shows that inhibiting the FGFR2 and EGFR proteins in pancreatic cells can delay or even prevent tumor formation.
Credit
Tuveson lab/CSHL
Usage Restrictions
Attribution required
License
Original content